FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Frontiers in microbiology2021; 12; 671676; doi: 10.3389/fmicb.2021.671676

Frequency, Local Dynamics, and Genomic Characteristics of ESBL-Producing Escherichia coli Isolated From Specimens of Hospitalized Horses.

Abstract: Previous research identified veterinary clinics as hotspots with respect to accumulation and spread of multidrug resistant extended-spectrum β-lactamase (ESBL)-producing (EC). Therefore, promoting the prudent use of antibiotics to decrease selective pressure in that particular clinical environment is preferable to enhance biosecurity for animal patients and hospital staff. Accordingly, this study comparatively investigated the impact of two distinct perioperative antibiotic prophylaxis (PAP) regimens (short-term versus prolonged) on ESBL-EC carriage of horses subjected to colic surgery. While all horses received a combination of penicillin/gentamicin (P/G) as PAP, they were assigned to either the "single-shot group" (SSG) or the conventional "5-day group" (5DG). Fecal samples collected on arrival (t), on the 3rd (t) and on the 10th day after surgery (t) were screened for ESBL-EC. All isolates were further investigated using whole genome sequences. In total, 81 of 98 horses met the inclusion criteria for this study. ESBL-EC identified in samples available at t, t and t were 4.8% (SSG) and 9.7% (5DG), 37% (SSG) and 47.2% (5DG) as well as 55.6% (SSG) and 56.8% (5DG), respectively. Regardless of the P/G PAP regimen, horses were 9.12 times (95% CI 2.79-29.7) more likely to carry ESBL-EC at t compared to t ( < 0.001) and 15.64 times (95% CI 4.57-53.55) more likely to carry ESBL-EC at t compared to t ( < 0.001). ESBL-EC belonging to sequence type (ST) 10, ST86, ST641, and ST410 were the most prevalent lineages, with (60%) being the dominant ESBL gene. A close spatio-temporal relationship between isolates sharing a particular ST was revealed by genome analysis, strongly indicating local spread. Consequently, hospitalization itself has a strong impact on ESBL-EC isolation rates in horses, possibly masking differences between distinct PAP regimens. The results of this study reveal accumulation and spread of multi-drug resistant ESBL-EC among horses subjected to colic surgery with different P/G PAP regimens, challenging the local hygiene management system and work-place safety of veterinary staff. Moreover, the predominance of particular ESBL-EC lineages in clinics providing health care for horses needs further investigation.
Copyright © 2021 Kauter, Epping, Ghazisaeedi, Lübke-Becker, Wolf, Kannapin, Stoeckle, Semmler, Günther, Gehlen and Walther.
Get Full Text
Publication Date: 2021-04-16 PubMed ID: 33936023PubMed Central: PMC8085565DOI: 10.3389/fmicb.2021.671676Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studies the impact of two types of perioperative antibiotic prophylaxis (short-term vs. prolonged) on the carriage of antibiotic-resistant Escherichia coli in horses after colic surgery. It found that hospitalisation significantly increases E. coli isolation rates, regardless of antibiotic regimen, indicating both a challenge for hygiene management and the need for further investigation on the dominance of particular E. coli strains in horse health clinics.

Background and Purpose of Study

  • The study was undertaken to explore the influence of two types of perioperative antibiotic prophylaxis (PAP) (single-shot vs. prolonged dosage) on the occurrence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in horses undergoing colic surgery.
  • These types of bacteria are resistant to many antibiotics, posing serious treatment difficulties. Prior studies have identified veterinary clinics as common locations for the spread and accumulation of these bacteria, which has implications for both patient (animal) and hospital staff safety.
  • Investigation of the impact of different antibiotic treatments aimed to propose better strategies to enhance biosecurity.

Methodology and Findings

  • All horses involved in the study received a combination of antibiotics (penicillin/gentamin, or P/G) as PAP, and were subsequently divided into two groups. The first group received a single-shot of this combination, while the second group was treated on a 5-day course.
  • Researchers examined fecal samples collected from the horses on the day of arrival, the 3rd day, and the 10th day post-surgery for the presence of the ESBL-EC.
  • Of the total 98 horses, 81 met the criteria to be included in the study. Isolation rates of ESBL-EC in these samples rose over time in both groups, indicating an increasing likelihood of the presence of the bacteria over the course of hospitalisation.
  • The genetic sequencing of isolates revealed the most prevalent strains, demonstrating a sequence pattern that suggested a local spread of the bacteria within the hospital environment.

Implications and Conclusion

  • The results showed that, regardless of antibiotic regimen, hospitalisation significantly amplified the isolation rates of ESBL-EC in horses. This could potentially overshadow the differences between the impacts of different PAP practices.
  • This suggests that local hygiene management practices and work-place safety precautions for veterinary staff should be evaluated and improved.
  • The study also highlighted the predominance of specific ESBL-EC strains in horse clinics, indicating a need for deeper investigation into the reasons for this dominance and how it can be managed.

Cite This Article

APA
Kauter A, Epping L, Ghazisaeedi F, Lübke-Becker A, Wolf SA, Kannapin D, Stoeckle SD, Semmler T, Günther S, Gehlen H, Walther B. (2021). Frequency, Local Dynamics, and Genomic Characteristics of ESBL-Producing Escherichia coli Isolated From Specimens of Hospitalized Horses. Front Microbiol, 12, 671676. https://doi.org/10.3389/fmicb.2021.671676

Publication

Frontiers in microbiology
ISSN: 1664-302X
NlmUniqueID: 101548977
Country: Switzerland
Language: English
Volume: 12
Pages: 671676
PII: 671676

Researcher Affiliations

Kauter, Anne
  • Advanced Light and Electron Microscopy (ZBS-4), Robert Koch Institute, Berlin, Germany.
Epping, Lennard
  • Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute, Berlin, Germany.
Ghazisaeedi, Fereshteh
  • Centre for Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Lübke-Becker, Antina
  • Centre for Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Wolf, Silver A
  • Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute, Berlin, Germany.
Kannapin, Dania
  • Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
Stoeckle, Sabita D
  • Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
Semmler, Torsten
  • Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute, Berlin, Germany.
Günther, Sebastian
  • Institute of Pharmacy, Universität Greifswald, Greifswald, Germany.
Gehlen, Heidrun
  • Equine Clinic, Surgery and Radiology, Freie Universität Berlin, Berlin, Germany.
Walther, Birgit
  • Advanced Light and Electron Microscopy (ZBS-4), Robert Koch Institute, Berlin, Germany.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 48 references
  1. Apostolakos I, Franz E, van Hoek AHAM, Florijn A, Veenman C, Sloet-van Oldruitenborgh-Oosterbaan MM, Dierikx C, van Duijkeren E. Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic.. J Antimicrob Chemother 2017 Jul 1;72(7):1915-1921.
    doi: 10.1093/jac/dkx072pubmed: 28333298google scholar: lookup
  2. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.. J Comput Biol 2012 May;19(5):455-77.
    doi: 10.1089/cmb.2012.0021pmc: PMC3342519pubmed: 22506599google scholar: lookup
  3. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF, Fagelhauer L, Chakraborty T, Neumann B, Werner G, Bender JK, Stingl K, Nguyen M, Coppens J, Xavier BB, Malhotra-Kumar S, Westh H, Pinholt M, Anjum MF, Duggett NA, Kempf I, Nykäsenoja S, Olkkola S, Wieczorek K, Amaro A, Clemente L, Mossong J, Losch S, Ragimbeau C, Lund O, Aarestrup FM. ResFinder 4.0 for predictions of phenotypes from genotypes.. J Antimicrob Chemother 2020 Dec 1;75(12):3491-3500.
    doi: 10.1093/jac/dkaa345pmc: PMC7662176pubmed: 32780112google scholar: lookup
  4. Bortolami A, Zendri F, Maciuca EI, Wattret A, Ellis C, Schmidt V, Pinchbeck G, Timofte D. Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing Escherichia coli From Companion Animals.. Front Microbiol 2019;10:1260.
    doi: 10.3389/fmicb.2019.01260pmc: PMC6560200pubmed: 31231344google scholar: lookup
  5. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, Møller Aarestrup F, Hasman H. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.. Antimicrob Agents Chemother 2014 Jul;58(7):3895-903.
    doi: 10.1128/aac.02412-14pmc: PMC4068535pubmed: 24777092google scholar: lookup
  6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing CLSI Supplement M100. 2018.
  7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals VET01SEd5E. 2020.
  8. Dallap Schaer BL, Linton JK, Aceto H. Antimicrobial use in horses undergoing colic surgery.. J Vet Intern Med 2012 Nov-Dec;26(6):1449-56.
    doi: 10.1111/j.1939-1676.2012.01024.xpubmed: 23167747google scholar: lookup
  9. de Lagarde M, Larrieu C, Praud K, Schouler C, Doublet B, Sallé G, Fairbrother JM, Arsenault J. Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β-lactamase/AmpC β-lactamase producing Escherichia coli in healthy horses in France in 2015.. J Vet Intern Med 2019 Mar;33(2):902-911.
    doi: 10.1111/jvim.15415pmc: PMC6430864pubmed: 30648296google scholar: lookup
  10. Díaz-Jiménez D, García-Meniño I, Herrera A, García V, López-Beceiro AM, Alonso MP, Blanco J, Mora A. Genomic Characterization of Escherichia coli Isolates Belonging to a New Hybrid aEPEC/ExPEC Pathotype O153:H10-A-ST10 eae-beta1 Occurred in Meat, Poultry, Wildlife and Human Diarrheagenic Samples.. Antibiotics (Basel) 2020 Apr 17;9(4).
    doi: 10.3390/antibiotics9040192pmc: PMC7235894pubmed: 32316613google scholar: lookup
  11. D'Souza AW, Potter RF, Wallace M, Shupe A, Patel S, Sun X, Gul D, Kwon JH, Andleeb S, Burnham CD, Dantas G. Spatiotemporal dynamics of multidrug resistant bacteria on intensive care unit surfaces.. Nat Commun 2019 Oct 8;10(1):4569.
    pmc: PMC6783542pubmed: 31594927doi: 10.1038/s41467-019-12563-1google scholar: lookup
  12. Falgenhauer L, Imirzalioglu C, Ghosh H, Gwozdzinski K, Schmiedel J, Gentil K, Bauerfeind R, Kämpfer P, Seifert H, Michael GB, Schwarz S, Pfeifer Y, Werner G, Pietsch M, Roesler U, Guerra B, Fischer J, Sharp H, Käsbohrer A, Goesmann A, Hille K, Kreienbrock L, Chakraborty T. Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany.. Int J Antimicrob Agents 2016 Jun;47(6):457-65.
    doi: 10.1016/j.ijantimicag.2016.03.019pubmed: 27208899google scholar: lookup
  13. Fischer J, Hille K, Ruddat I, Mellmann A, Köck R, Kreienbrock L. Simultaneous occurrence of MRSA and ESBL-producing Enterobacteriaceae on pig farms and in nasal and stool samples from farmers.. Vet Microbiol 2017 Feb;200:107-113.
    doi: 10.1016/j.vetmic.2016.05.021pubmed: 27328620google scholar: lookup
  14. Gehlen H, Simon C, Reinhold-Fritzen B, Lübke-Becker A, Kauter A, Walther B. Biosecurity measures for equine clinics and ambulatory practice. Berl. Munch. Tierarztl. Wochenschr. 133.
    doi: 10.2376/1439-0299-2020-3google scholar: lookup
  15. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG Jr. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.. Emerg Infect Dis 2007 Aug;13(8):1144-9.
    doi: 10.3201/eid1308.070071pmc: PMC2828082pubmed: 17953083google scholar: lookup
  16. Hordijk J, Farmakioti E, Smit LAM, Duim B, Graveland H, Theelen MJP, Wagenaar JA. Fecal Carriage of Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli in Horses.. Appl Environ Microbiol 2020 Apr 1;86(8).
    doi: 10.1128/AEM.02590-19pmc: PMC7117932pubmed: 32033947google scholar: lookup
  17. Huijbers PM, de Kraker M, Graat EA, van Hoek AH, van Santen MG, de Jong MC, van Duijkeren E, de Greeff SC. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density.. Clin Microbiol Infect 2013 Jun;19(6):E256-9.
    pubmed: 23397953doi: 10.1111/1469-0691.12150google scholar: lookup
  18. Isgren CM, Edwards T, Pinchbeck GL, Winward E, Adams ER, Norton P, Timofte D, Maddox TW, Clegg PD, Williams NJ. Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008-2017).. BMC Vet Res 2019 Jul 29;15(1):268.
    doi: 10.1186/s12917-019-2011-9pmc: PMC6664770pubmed: 31357996google scholar: lookup
  19. Kaspar U, von Lützau K, Schlattmann A, Rösler U, Köck R, Becker K. Zoonotic multidrug-resistant microorganisms among non-hospitalized horses from Germany.. One Health 2019 Jun;7:100091.
    doi: 10.1016/j.onehlt.2019.100091pmc: PMC6468158pubmed: 31016221google scholar: lookup
  20. Köck R, Cuny C, Witte W, Fetsch A, Tenhagen B-A, Becker K. One Health Interventions to Prevent Zoonotic Spread of Antimicrobial Multidrug-Resistant Bacterial Microorganisms (#1Health-PREVENT). .
  21. Li Q, Chang W, Zhang H, Hu D, Wang X. The Role of Plasmids in the Multiple Antibiotic Resistance Transfer in ESBLs-Producing Escherichia coli Isolated From Wastewater Treatment Plants.. Front Microbiol 2019;10:633.
    doi: 10.3389/fmicb.2019.00633pmc: PMC6456708pubmed: 31001218google scholar: lookup
  22. Ludden C, Decano AG, Jamrozy D, Pickard D, Morris D, Parkhill J, Peacock SJ, Cormican M, Downing T. Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones.. Microb Genom 2020 Apr;6(4).
    doi: 10.1099/mgen.0.000352pmc: PMC7276707pubmed: 32213258google scholar: lookup
  23. Lupo A, Haenni M, Saras E, Gradin J, Madec JY, Börjesson S. Is bla(CTX-M-1) Riding the Same Plasmid Among Horses in Sweden and France?. Microb Drug Resist 2018 May 24;.
    doi: 10.1089/mdr.2017.0412pubmed: 29792781google scholar: lookup
  24. Maddox TW, Clegg PD, Diggle PJ, Wedley AL, Dawson S, Pinchbeck GL, Williams NJ. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 1: Prevalence of antimicrobial-resistant Escherichia coli and methicillin-resistant Staphylococcus aureus.. Equine Vet J 2012 May;44(3):289-96.
    doi: 10.1111/j.2042-3306.2011.00441.xpubmed: 21848534google scholar: lookup
  25. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, Fookes M, Falush D, Keane JA, Parkhill J. Roary: rapid large-scale prokaryote pan genome analysis.. Bioinformatics 2015 Nov 15;31(22):3691-3.
    doi: 10.1093/bioinformatics/btv421pmc: PMC4817141pubmed: 26198102google scholar: lookup
  26. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Böttger EC, Hombach M. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.. J Clin Microbiol 2011 Aug;49(8):2798-803.
    doi: 10.1128/jcm.00404-11pmc: PMC3147735pubmed: 21632895google scholar: lookup
  27. Reynolds ME, Phan HTT, George S, Hubbard ATM, Stoesser N, Maciuca IE, Crook DW, Timofte D. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK.. J Antimicrob Chemother 2019 May 1;74(5):1207-1211.
    doi: 10.1093/jac/dkz017pubmed: 30753576google scholar: lookup
  28. Roer L, Overballe-Petersen S, Hansen F, Schønning K, Wang M, Røder BL, Hansen DS, Justesen US, Andersen LP, Fulgsang-Damgaard D, Hopkins KL, Woodford N, Falgenhauer L, Chakraborty T, Samuelsen Ø, Sjöström K, Johannesen TB, Ng K, Nielsen J, Ethelberg S, Stegger M, Hammerum AM, Hasman H. Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones.. mSphere 2018 Jul 18;3(4).
    doi: 10.1128/mSphere.00337-18pmc: PMC6052333pubmed: 30021879google scholar: lookup
  29. Royden A, Ormandy E, Pinchbeck G, Pascoe B, Hitchings MD, Sheppard SK, Williams NJ. Prevalence of faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in veterinary hospital staff and students.. Vet Rec Open 2019;6(1):e000307.
    doi: 10.1136/vetreco-2018-000307pmc: PMC6327872pubmed: 30687506google scholar: lookup
  30. Schaufler K, Semmler T, Wieler LH, Wöhrmann M, Baddam R, Ahmed N, Müller K, Kola A, Fruth A, Ewers C, Guenther S. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410--another successful pandemic clone?. FEMS Microbiol Ecol 2016 Jan;92(1).
    doi: 10.1093/femsec/fiv155pubmed: 26656065google scholar: lookup
  31. Schoster A, van Spijk JN, Damborg P, Moodley A, Kirchgaessner C, Hartnack S, Schmitt S. The effect of different antimicrobial treatment regimens on the faecal shedding of ESBL-producing Escherichia coli in horses.. Vet Microbiol 2020 Apr;243:108617.
    doi: 10.1016/j.vetmic.2020.108617pubmed: 32273003google scholar: lookup
  32. Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson AP, Gaastra W. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals.. J Antimicrob Chemother 2010 Apr;65(4):601-4.
    doi: 10.1093/jac/dkq037pubmed: 20181573google scholar: lookup
  33. Seemann T. Prokka: rapid prokaryotic genome annotation.. Bioinformatics 2014 Jul 15;30(14):2068-9.
    doi: 10.1093/bioinformatics/btu153pubmed: 24642063google scholar: lookup
  34. Shnaiderman-Torban A, Navon-Venezia S, Dor Z, Paitan Y, Arielly H, Ahmad WA, Kelmer G, Fulde M, Steinman A. Extended-Spectrum β-lactamase-Producing Enterobacteriaceae Shedding in Farm Horses Versus Hospitalized Horses: Prevalence and Risk Factors.. Animals (Basel) 2020 Feb 11;10(2).
    doi: 10.3390/ani10020282pmc: PMC7070874pubmed: 32054111google scholar: lookup
  35. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies.. Bioinformatics 2014 May 1;30(9):1312-3.
    doi: 10.1093/bioinformatics/btu033pmc: PMC3998144pubmed: 24451623google scholar: lookup
  36. Swedish Veterinary Association. The Swedish Veterinary Association’s Guidelines for the Clinical Use of Antibiotics in the Treatment of Horses. 2013.
  37. Teschner D, Barton AK, Klaus C, Gehlen H. Antimicrobial drug use in horses undergoing colic surgery in Germany. Pferdeheilkunde 31 235–240.
    doi: 10.21836/pem20150305google scholar: lookup
  38. Touchon M, Perrin A, de Sousa JAM, Vangchhia B, Burn S, O'Brien CL, Denamur E, Gordon D, Rocha EP. Phylogenetic background and habitat drive the genetic diversification of Escherichia coli.. PLoS Genet 2020 Jun;16(6):e1008866.
    doi: 10.1371/journal.pgen.1008866pmc: PMC7314097pubmed: 32530914google scholar: lookup
  39. van Spijk JN, Schmitt S, Schoster A. Infections caused by multidrug-resistant bacteria in an equine hospital (2012–2015). Equine Vet. Educ. 31 653–658.
    doi: 10.1111/eve.12837google scholar: lookup
  40. Walther B, Janssen T, Gehlen H, Vincze S, Borchers K, Wieler LH, Barton AK, Lübke-Becker A. [Infection control and hygiene management in equine hospitals].. Berl Munch Tierarztl Wochenschr 2014 Nov-Dec;127(11-12):486-97.
    pubmed: 25872258
  41. Walther B, Klein KS, Barton AK, Semmler T, Huber C, Merle R, Tedin K, Mitrach F, Lübke-Becker A, Gehlen H. Equine Methicillin-Resistant Sequence Type 398 Staphylococcus aureus (MRSA) Harbor Mobile Genetic Elements Promoting Host Adaptation.. Front Microbiol 2018;9:2516.
    doi: 10.3389/fmicb.2018.02516pmc: PMC6207647pubmed: 30405574google scholar: lookup
  42. Walther B, Klein KS, Barton AK, Semmler T, Huber C, Wolf SA, Tedin K, Merle R, Mitrach F, Guenther S, Lübke-Becker A, Gehlen H. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: The contemporary "Trojan Horse".. PLoS One 2018;13(1):e0191873.
    doi: 10.1371/journal.pone.0191873pmc: PMC5790241pubmed: 29381714google scholar: lookup
  43. Walther B, Lübke-Becker A, Stamm I, Gehlen H, Barton AK, Janssen T, Wieler LH, Guenther S. Suspected nosocomial infections with multi-drug resistant E. coli, including extended-spectrum beta-lactamase (ESBL)-producing strains, in an equine clinic.. Berl Munch Tierarztl Wochenschr 2014 Nov-Dec;127(11-12):421-7.
    pubmed: 25872251
  44. Walther B, Tedin K, Lübke-Becker A. Multidrug-resistant opportunistic pathogens challenging veterinary infection control.. Vet Microbiol 2017 Feb;200:71-78.
    doi: 10.1016/j.vetmic.2016.05.017pubmed: 27291944google scholar: lookup
  45. Weese J, Baptiste K, Baverud V, Toutain P-L. Guidelines for antimicrobial use in horses. Guide to Antimicrobial use in Animals 2008.
  46. Wieler LH, Ewers C, Guenther S, Walther B, Lübke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.. Int J Med Microbiol 2011 Dec;301(8):635-41.
    doi: 10.1016/j.ijmm.2011.09.009pubmed: 22000738google scholar: lookup
  47. Wright JG, Tengelsen LA, Smith KE, Bender JB, Frank RK, Grendon JH, Rice DH, Thiessen AM, Gilbertson CJ, Sivapalasingam S, Barrett TJ, Besser TE, Hancock DD, Angulo FJ. Multidrug-resistant Salmonella Typhimurium in four animal facilities.. Emerg Infect Dis 2005 Aug;11(8):1235-41.
    pmc: PMC3320505pubmed: 16102313doi: 10.3201/eid1108.050111google scholar: lookup
  48. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. Identification of acquired antimicrobial resistance genes.. J Antimicrob Chemother 2012 Nov;67(11):2640-4.
    doi: 10.1093/jac/dks261pmc: PMC3468078pubmed: 22782487google scholar: lookup

Citations

This article has been cited 8 times.
  1. Werner G, Abu Sin M, Bahrs C, Brogden S, Feßler AT, Hagel S, Kaspar H, Köck R, Kreienbrock L, Krüger-Haker H, Maechler F, Noll I, Pletz MW, Tenhagen BA, Schwarz S, Walther B, Mielke M. [Therapy-relevant antibiotic resistances in a One Health context]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2023 Jun;66(6):628-643.
    doi: 10.1007/s00103-023-03713-4pubmed: 37184673google scholar: lookup
  2. Theelen MJP, Luiken REC, Wagenaar JA, Sloet van Oldruitenborgh-Oosterbaan MM, Rossen JWA, Schaafstra FJWC, van Doorn DA, Zomer AL. Longitudinal study of the short- and long-term effects of hospitalisation and oral trimethoprim-sulfadiazine administration on the equine faecal microbiome and resistome. Microbiome 2023 Feb 27;11(1):33.
    doi: 10.1186/s40168-023-01465-6pubmed: 36850017google scholar: lookup
  3. Gehlen H, Klein KS, Merle R, Lübke-Becker A, Stoeckle SD. Does colonization with MRSA, ESBL - producing Enterobacteriaceae, and/or Acinetobacter baumannii - increase the risk for postoperative surgical site infection?. Vet Med Sci 2023 Mar;9(2):729-737.
    doi: 10.1002/vms3.1073pubmed: 36646070google scholar: lookup
  4. Feßler AT, Scholtzek AD, Schug AR, Kohn B, Weingart C, Hanke D, Schink AK, Bethe A, Lübke-Becker A, Schwarz S. Antimicrobial and Biocide Resistance among Canine and Feline Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii Isolates from Diagnostic Submissions. Antibiotics (Basel) 2022 Jan 25;11(2).
    doi: 10.3390/antibiotics11020152pubmed: 35203754google scholar: lookup
  5. Rossi GAM, Sellera FP, Ferraz CM, Carvalho RS, Oliveira APL, Marques CA, Fávaro EBR, Rosa RDS, Silva LAM, Cardozo MV, Stehling EG, Furlan JPR. Antimicrobial-Resistant Enteric Gram-Negative Bacteria Isolated from a Fatal Diarrhea in a Horse: Genomic Characterization of CTX-M-2-Producing Escherichia coli. Antibiotics (Basel) 2025 Nov 21;14(12).
    doi: 10.3390/antibiotics14121185pubmed: 41463689google scholar: lookup
  6. Merle R, Feuer L, Frenzer K, Plenio JL, Bethe A, Sarnino N, Lübke-Becker A, Bäumer W. Antibiotic Use in Horses: Analysis of 57 German Veterinary Practices (2018-2023). Antibiotics (Basel) 2025 Sep 19;14(9).
    doi: 10.3390/antibiotics14090953pubmed: 41009931google scholar: lookup
  7. Kabir A, Lamichhane B, Habib T, Adams A, El-Sheikh Ali H, Slovis NM, Troedsson MHT, Helmy YA. Antimicrobial Resistance in Equines: A Growing Threat to Horse Health and Beyond-A Comprehensive Review. Antibiotics (Basel) 2024 Jul 29;13(8).
    doi: 10.3390/antibiotics13080713pubmed: 39200013google scholar: lookup
  8. Kauter A, Brombach J, Lübke-Becker A, Kannapin D, Bang C, Franzenburg S, Stoeckle SD, Mellmann A, Scherff N, Köck R, Guenther S, Wieler LH, Gehlen H, Semmler T, Wolf SA, Walther B. Antibiotic prophylaxis and hospitalization of horses subjected to median laparotomy: gut microbiota trajectories and abundance increase of Escherichia. Front Microbiol 2023;14:1228845.
    doi: 10.3389/fmicb.2023.1228845pubmed: 38075913google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.